Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Guardant Health stock
Learn how to easily invest in Guardant Health stock.
Guardant Health Inc is a diagnostics & research business based in the US. Guardant Health shares (GH) are listed on the NASDAQ and all prices are listed in US Dollars. Guardant Health employs 1,373 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Guardant Health
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Guardant Health stock price (NASDAQ: GH)Use our graph to track the performance of GH stocks over time.
Guardant Health shares at a glance
|Latest market close||$43.66|
|52-week range||$27.65 - $133.82|
|50-day moving average||$43.39|
|200-day moving average||$76.90|
|Wall St. target price||$117.73|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-4.13|
Buy Guardant Health shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Guardant Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Guardant Health price performance over time
|1 week (2022-06-29)||3.85%|
|1 month (2022-06-02)||N/A|
|3 months (2022-04-06)||-39.45%|
|6 months (2022-01-06)||-51.62%|
|1 year (2021-07-06)||-64.86%|
|2 years (2020-07-06)||-48.78%|
|3 years (2019-07-05)||86|
|5 years (2017-07-02)||N/A|
Guardant Health financials
|Revenue TTM||$391.1 million|
|Gross profit TTM||$250.7 million|
|Return on assets TTM||-11.78%|
|Return on equity TTM||-55.66%|
|Market capitalisation||$4.4 billion|
TTM: trailing 12 months
Guardant Health share dividends
We're not expecting Guardant Health to pay a dividend over the next 12 months.
Guardant Health share price volatility
Over the last 12 months, Guardant Health's shares have ranged in value from as little as $27.65 up to $133.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Guardant Health's is 0.7226. This would suggest that Guardant Health's shares are less volatile than average (for this exchange).
Guardant Health overview
Guardant Health, Inc. , a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.
Guardant Health in the news
Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture
Frequently asked questionsWhat percentage of Guardant Health is owned by insiders or institutions?
Currently 4.724% of Guardant Health shares are held by insiders and 93.478% by institutions. How many people work for Guardant Health?
Latest data suggests 1,373 work at Guardant Health. When does the fiscal year end for Guardant Health?
Guardant Health's fiscal year ends in December. Where is Guardant Health based?
Guardant Health's address is: 505 Penobscot Drive, Redwood City, CA, United States, 94063 What is Guardant Health's ISIN number?
Guardant Health's international securities identification number is: US40131M1099 What is Guardant Health's CUSIP number?
Guardant Health's Committee on Uniform Securities Identification Procedures number is: 40131M109
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert